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Mutations in the eye lens gap junction protein connexin 50 cause cataract. Earlier we identiﬁed a
frameshift mutant of connexin 50 (c.670insA; p.Thr203AsnfsX47) in a family with autosomal recessive
cataract. The mutant protein is smaller and contains 46 aberrant amino acids at the C-terminus after
amino acid 202. Here, we have analysed this frameshift mutant and observed that it localized to the
endoplasmic reticulum (ER) but not in the plasmamembrane. Moreover, overexpression of the mutant
resulted in disintegration of the ER-Golgi intermediate compartment (ERGIC), reduction in the level of
ERGIC-53 protein and breakdown of the Golgi in many cells. Overexpression of the frameshift mutant
partially inhibited the transport of wild type connexin 50 to the plasma membrane. A deletion mutant
lacking the aberrant sequence showed predominant localization in the ER and inhibited anterograde
protein transport suggesting, therefore, that the aberrant sequence is not responsible for improper
localization of the frameshiftmutant. Further deletion analysis showed that the fourth transmembrane
domain and amembrane proximal region (231–294 amino acids) of the cytoplasmic domain are needed
for transport from the ER and localization to the plasmamembrane. Our results show that a frameshift
mutant of connexin 50 mislocalizes to the ER and causes disintegration of the ERGIC and Golgi. We
have also identiﬁed a sequence of connexin 50 crucial for transport from the ER and localization to the
plasma membrane.
C© 2012 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical
Societies.Open access under CC BY-NC-ND license.. Introduction
Cataract is a visible opacity in the eye lens leading to partial or
omplete loss of transparency. It accounts for a major proportion of
mpaired vision and blindness worldwide. Congenital cataract is the
eading cause of reversible blindness in childhood [1,2] and inherited
ataracts account for 8–25%of congenital cataracts [2]. It is genetically
eterogeneous and mutations in several classes of candidate genes
ncluding crystallins and connexins have been linked to the disease
2]. The eye lens is a transparent, avascular organ that transmits and
ocuses light energy on the retina. The human lens has three mainAbbreviations: Cx50, connexin 50; ER, endoplasmic reticulum; ERGIC, ER-Golgi in-
ermediate compartment; TGN, trans-Golgi network
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ttp://dx.doi.org/10.1016/j.fob.2012.11.005parts, viz., lens capsule, lens epithelium and lens ﬁbres. During the
process of lens development towards the stage of maturation, human
lens undergoes denucleation and degradation of various cytoplas-
mic organelles in the lens ﬁbre cells to establish and maintain lens
transparency [3,4]. The lens has developed an extensive cell to cell
communication system via gap junction channels so that the cells in
the central region can communicatewith the cells on the surface. This
is necessary for the exchange of ions andmetabolites in the avascular
lens, thus crucial for maintaining lens homeostasis and transparency
[4].
Gap junctions are transmembrane channels formed by connex-
ins allowing the exchange of small molecules and ions (Mr≤ 1000
Da) between two closely apposed neighbouring cells [5]. Each con-
nexin sub-unit consists of four α-helical transmembrane domains
(M1–M4), two extracellular loops (E1 and E2), one cytoplasmic loop
(CL) between second and third transmembrane domain and cytoplas-
mic amino terminal (NT) and carboxy terminal (CT) domains [6,7]. Six
such connexin sub-units assemble to form a functional membrane
hemichannel, also called connexon. Different connexin isotypes in-
teract selectively with each other resulting in the assembly of homo-
oligomeric or hetero-oligomeric connexons [7,8]. When two cells arean Biochemical Societies.Open access under CC BY-NC-ND license.
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Fig. 1. Sub-cellular localization of wild type and the frameshift mutant of connexin 50.
(A) Line diagramdepicting the domain structure ofwild type connexin 50 (Cx50) and its
frameshift mutant (Cx50-FS). (B) Hela cells grown on coverslips were transfected with
either Cx50-myc or Cx50-FS-myc constructs andwereﬁxed25hpost transfection. Cells
were stained with anti-mycmousemonoclonal antibody and analysed by confocal mi-
croscopy. (C) Western blot showing expression of Cx50 and Cx50-FS constructs. Cdk2
was used as a loading control. (D) Cx50-myc and Cx50-FS-myc transfected cells were
stained with anti-myc antibody (red) and calnexin rabbit polyclonal antibody (an ER
marker) (green) and colocalization was observed by confocal microscopy. Colocaliza-
tion of the frameshift mutant with calnexin was shown by merging of red with green
showing yellow colour in the merged image panel. Scale bar: 10 μm. (E) The graph
shows the correlation coefﬁcients of colocalization of Cx50 and Cx50-FS with calnexin.
The data shown here is the mean ± SD of 80 cells with each construct. ***p < 0.001.
(F) Hela cells transfected with Cx50 and Cx50-FS-myc constructs were immunostained
with anti-myc antibody (red) and β-catenin mouse monoclonal antibody (green) and
analysed by confocal microscopy. Colocalization of the Cx50 and β-catenin at the cell
junctions can be seen by bright yellow colour at the appositional membranes whereas
Cx50-FS showed intracellular localization and no colocalization with β-catenin at the
plasmamembrane. (For interpretation of the references to colour in this ﬁgure legend,
the reader is referred to the web version of this article.)closely apposed, connexon in one cell docks with its counterpart in
the apposing cell forming a gap junction. Connexins are synthesized
in the endoplasmic reticulum (ER) and are oligomerized in the ER,
Golgi or trans-Golgi network, depending on the type of connexin, to
form connexons [8–10]. These connexons ﬁnally move to the plasma
membrane in vesicular structures along microtubules. The domain
requirements for targeting or transport of connexins to the plasma
membrane are not clear. Connexins are ubiquitously expressed in
mammalian cells and in humans 21 different connexin genes are
reported so far, mutations in which cause various diseases includ-
ing cataracts [1,7,11]. In the eye, three lens speciﬁc connexins exist
where GJA1(Cx43) is speciﬁc to lens epithelial cells, GJA3(Cx46) in
lens ﬁbre cells and GJA8(Cx50) in both lens epithelium and ﬁbre cells
[7]. Mutations in connexin 50 (Cx50) occur in all parts of the gene
[7,12–23] and no correlation has been detected between the muta-
tion location and cataractogenesis. Majority of the mutations known
cause autosomal dominant cataracts and only two mutations of re-
cessive inheritance are reported [6,18,20,21]. Studies using knockout
mouse models showed that the deletion of Cx50 results in signiﬁ-
cantly reduced size of lens and eye (microphthalmia) in addition to
mild nuclear cataract [24].
The mutant of Cx50 studied here was reported earlier by us in
a South Indian family with autosomal recessive cataract (c.670insA;
p.Thr203AsnfsX47) [20]. This mutation is a single base insertion in
the codon 203, which is in the second extracellular domain, leading
to frameshift and translation of 46 aberrant amino acids followed by
truncation. This causes loss of fourth transmembrane domain and in-
tracellular carboxy terminal domain. The schematic of wild type con-
nexin 50 (Cx50-WT) and the frameshift mutant (Cx50-FS) are shown
in Fig. 1(A).
Here, we have analysed subcellular localization and consequence
of expression of this frameshift mutant.We observed that themutant
protein is localized mainly in the ER and does not go to the plasma
membrane. We also explored the mechanism of this altered localiza-
tion by analysing the localization of various deletion mutants. Our
results show that the aberrant sequence generated by frameshift is
not responsible for altered sub-cellular localization. We also show
that 4th transmembrane domain and a membrane proximal region
of C-terminal cytoplasmic domain are important for localization of
connexin 50 to the plasma membrane. The frameshift mutant causes
disruption of protein trafﬁcking and breakdown of organelles of the
early secretory pathway. Our results suggest that defective transport
and localization of the frameshift mutant to the plasma membrane
is likely to cause loss of connexin 50 function leading to recessive
cataract.
2. Materials and methods
2.1. Expression vectors
The study protocol had been approved by the institutional review
board of the L.V. Prasad Eye Institute where the subjects were re-
cruited after complete ophthalmic examination. Blood samples were
obtained after informed written consent from the participants. Hu-
man wild type connexin 50 (Cx50) and Cx50-FS mutant were ampli-
ﬁed from the DNA isolated from the patient’s blood samples using
gene speciﬁc primers with EcoRI and HindIII sites in the forward and
reverse primers, respectively. The ampliﬁed product was cloned in
the EcoRI and HindIII sites of pcDNA 3.1/myc–His(–) A vector with
myc and His tag at the 3′-end of the cDNA. Cx50 was also cloned in
the EcoRI and XhoI sites of pEGFP-N1 vector with GFP tag at the 3′-end
of the cDNA. Similar to Cx50, deletion constructs Cx50-202, Cx50-230
and Cx50-294 were also cloned in the EcoRI and HindIII sites of the
pcDNA 3.1/myc–His(–) A vector with myc and His tag at the 3′-end
of the cDNA. GFP-TC48 has been described previously [25].2.2. Antibodies
Calnexin, anti-myc (rabbit polyclonal and mouse monoclonal),
mouse monoclonal β-catenin, rabbit polyclonal TGN-38 and rab-
bit polyclonal cdk2 antibodies were from Santa Cruz Biotechnology.
Mouse monoclonal anti-ERGIC-53 antibody was obtained from Enzo
Lifesciences. The rabbit polyclonal anti-Giantin antibodywas fromCo-
vance. The rabbit polyclonal anti-Sec24C antibody was a gift from Dr.
William E. Balch (Scripps Research Institute). The mouse monoclonal
β-cop antibody was from Sigma. The mouse monoclonal GAPDH an-
tibody was from Millipore. Secondary antibodies Cy-3 conjugated
anti-mouse and anti-rabbit IgG were from Amersham. Alexa-488 and
Alexa-633 conjugated anti-mouse and anti-rabbit IgGs andAlexa-594
conjugated anti-rabbit IgG were from Molecular Probes. HRP conju-
gated anti-mouse and anti-rabbit IgGs were from Amersham.
24 Madhavi Latha Somaraju Chalasani et al. / FEBS Open Bio 3 (2013) 22–29
2
o
c
s
u
L
U
r
t
c
2
s
w
i
P
a
w
i
b
a
d
w
f
w
c
d
u
i
u
s
c
w
i
2
p
m
m
i
1
p
n
c
(
s
m
s
2
c
t
d.3. Cell culture and transfections
Hela cells were grown as monolayers in a humidiﬁed atmosphere
f 5% CO2 at 37
◦C in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM)
ontaining 10% fetal calf serum, 100 U/ml penicillin and 100 μg/ml
treptomycin. Transient transfections in Hela cells were performed
sing Qiagen column (Qiagen, Valencia, CA) puriﬁed plasmids and
ipofectamine PLUS or Lipofectamine 2000 (Invitrogen, SanDiego, CA,
SA) according to the manufacturer’s instructions. For immunoﬂuo-
escence staining, cells grown on coverslips were transfected with
he required plasmids. For Cos-1 cells transfections were done with
ationic lipid DHDEAB as described [26,27].
.4. Indirect immunoﬂuorescence and confocal microscopy
Indirect immunoﬂuorescence was carried out essentially as de-
cribedpreviously [27,28]. Cells grownon coverslipswere transfected
ith required plasmids and after 25 h ﬁxed with 3.7% formaldehyde
n PBS for 10min at room temperature. These cells were washedwith
BS three times and permeabilized for 6 min with 0.5% Triton-X-100
nd0.05%Tween-20prepared in PBS at roomtemperature. After three
asheswith PBS, the permeabilized cellswere incubatedwith 2% BSA
n PBS for 1 h at room temperature to prevent non-speciﬁc antibody
inding. Cells were then incubated in required dilution of primary
ntibody in 2% BSA for 2 h at room temperature or overnight at 4 ◦C
epending on the antibody. Unbound antibodies were removed by
ashing with PBS and cells were stained with secondary antibody
or 1 h. After washing with PBS again, stained cells were mounted
ith Vectashield mounting medium (Vector labs, Molecular Probes)
ontaining DAPI.
For studying colocalizations, stained coverslipswere observed un-
er LSM 510 Meta Confocal Microscope and images were captured
sing 63X/1.4 NA oil immersion objectives. Similar parameters of
mage capture were used for analysis of cells belonging to a partic-
lar experiment. Colocalizations were determined by observing the
taining pattern and two middle sections were projected to observe
olocalization using LSM 510 (version 3.2) software. Colocalizations
ere quantitated by calculating Pearson’s correlation coefﬁcients us-
ng the LSM 510 software.
.5. Co-immunoprecipitation
Hela cells plated in 35-mm dishes were transfected with required
lasmids, overexpressed for 30 h, lysed in lysis buffer containing 25
M Tris–HCl, pH 7.4, 150 mM NaCl, 0.1% BSA, 1.0% Triton-X-100, 1
M PMSF, 5 mM EDTA, protease inhibitor cocktail (Roche Biochem-
cals) for 20 min at 4 ◦C. Lysates were collected and centrifuged at
0000 gfor 14 min at 4 ◦C. The supernatant was used for immuno-
recipation with 2 μg of c-myc rabbit polyclonal antibody or 2 μg of
ormal rabbit IgG control antibody and incubated for 8 h at 4 ◦C. The
omplexes were precipitated using protein A/G Plus agarose beads
Santa Cruz Biotechnology), washed and lysed in 20 μl of 3X SDS-
ample buffer (180mM Tris–Hcl pH 6.8, 6% SDS, 15% glycerol, 7.5% β-
ercaptoethanol, 0.01% bromophenol blue). The samples were then
ubjected to SDS–PAGE followed by western blotting.
.6. SDS–PAGE and western blotting
The proteins were resolved by SDS–PAGE and transferred to nitro-
ellulose membrane (Hybond-ECL from Amersham) using semi-dry
ransfer apparatus (Amersham). Western blot analysis was done as
escribed [25].2.7. Statistical analysis
Statistical signiﬁcance of differences among experimental groups
was assessed by Student’s t test for populations with unequal vari-
ance. P values less than 0.05 were considered statistically signiﬁcant.
The level of signiﬁcance was shown at 3 levels, viz., *0.05, **0.01 and
***0.001.
3. Results
3.1. Subcellular localization of mutant connexin 50
Earlier studies have shown that wild type Cx50 is localized to the
plasmamembrane and the appositionalmembranes [15,23]. To study
the sub-cellular localization of the frameshift mutant, Hela cells were
transfected with either the plasmid expressing wild type connexin
50 (Cx50-myc) or its frameshift mutant (Cx50-FS-myc). After 25 h
of expression, the cells were ﬁxed and stained with myc antibody
and analysed by confocal microscopy. As previously known, the wild
type protein localized to the plasma membrane, to the appositional
membranes of two juxtaposed cells and also to distinct cytoplasmic
foci (Fig. 1(B)). In contrast, Cx50-FS mutant protein did not localize to
the plasma membrane but it showed distinct tubular/reticular pat-
tern in the cytoplasm, which resembled the characteristic ER staining
in a cell (Fig. 1(B)). The expression of Cx50 and Cx50-FS constructs
was also checked by western blot with myc antibody (Fig. 1(C)). To
determine whether Cx50-FS mutant localized to the ER, Hela cells
expressing Cx50-FS mutant were co-stained for the ER marker, cal-
nexin. Cx50-FS mutant showed colocalization with calnexin, which
suggested that Cx50-FS mutant was present predominantly in the
ER (Fig. 1(D)). Quantitative analysis of colocalization was carried out
by calculating correlation coefﬁcients of colocalization. Compared to
wild type connexin 50, the frameshift mutant showed signiﬁcantly
more colocalization with calnexin (Fig. 1(E)). Unlike wild type con-
nexin 50, the frameshift mutant rarely formed foci or aggregates.
Plasma membrane localization of wild type Cx50 was conﬁrmed by
co-staining of transfected cells with β-catenin. In normal epithelial
cells, β-catenin is found at the plasmamembrane where it provides a
mechanical linkage between cell-to-cell junctional proteins [29,30].
Cx50-WT showed colocalization with β-catenin in the plasma mem-
brane whereas Cx50-FS did not (Fig. 1(F)).
Some proteins showmisfolding ormislocalization at 37 ◦C but this
defect can be rescued at lower temperature. However, the frameshift
mutant of connexin 50 showed no localization to the plasma mem-
brane even when transfected cells were kept at 30 ◦C (Fig. S1).
3.2. Frameshift mutant overexpression causes disintegration of the
ERGIC and breakdown of the Golgi
As we observed that Cx50-FS mutant localized to the ER, we were
interested to see if it also localized to the ER-Golgi intermediate com-
partment (ERGIC) and Golgi. Hela cells were transfected with either
Cx50 or Cx50-FS mutant and after 25 h of expression the cells were
ﬁxed and immunostained with myc antibody and ERGIC-53 (marker
for the ERGIC) antibody or giantin (marker for the Golgi) antibody or
TGN-38 (marker for trans Golgi network), and analysed using con-
focal microscopy. Surprisingly, we observed that overexpression of
Cx50-FS mutant caused disintegration of the ERGIC in 53% of the
transfected cells, whereas only 13% of the cells overexpressing wild
type connexin 50 showed disintegration of the ERGIC (Fig. 2(A) and
(B)). GFP transfected cells showed disintegration of the ERGIC in 12%
of the cells (ﬁgure not shown). Moreover, overexpression of Cx50-FS
mutant led to 48% decrease in ERGIC-53 protein level, as analysed by
western blotting, whereas Cx50 expression caused some increase in
ERGIC-53protein level (Fig. 2(C)). In the cellswhere ERGIC-53 staining
was unaffected, the frameshift mutant showed some colocalization
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Fig. 2. The frameshift mutant causes disruption of the ERGIC and Golgi. Hela cells
transfected with Cx50 and Cx50-FS constructs were ﬁxed after 25 h of transfection and
immunostained with anti-myc and ERGIC-53 (A) antibody or Giantin (D) antibody or
TGN-38 (G) antibody. The analysis was done by confocal microscopy. Scale bar: 10 μm.
(B) Graph showing percentage of cells with ERGIC disruption in cells expressing (exp)
or not expressing (non-exp) connexin 50 constructs. ***p < 0.001. (E) Graph showing
percentage of cells with Golgi breakdown. ***p< 0.001. (H) Graph showing percentage
of cells with TGN breakdown. ***p < 0.001. The results shown in B, E and H are the
means ± SD of six experiments. A total of 900 cells were counted with each construct.
Hela cells plated in 35 mm dishes were transfected with a control plasmid or Cx50-
myc or Cx50-FS myc. After 48 h of transfection, cell lysates were made and subjected
to western blotting with ERGIC-53, β-COP and myc antibodies (C) or Giantin and myc
antibodies (F). GAPDH was used as a loading control in both the blots.
Fig. 3. Subcellular localization of deletion constructs of connexin 50 in Hela cells. (A)
Schematic of wild type connexin 50 and its deletion constructs. The transmembrane
domains are shown as M1–M4. (B) Hela cells transfected with myc and GFP tagged
wild type and various deletion constructs of Cx50 were ﬁxed after 25 h of transfection.
Cells were stained with anti-myc antibody and subcellular localization was studied by
confocal microscopy. Scale bar: 10 μm. (C) Bar diagram showing percentage of cells
with plasma membrane staining in cells expressing various myc constructs. The graph
showsmean ± SDof150cellswitheach construct. (D)Bardiagramshowingpercentage
of cells with plasma membrane staining in cells expressing Cx50-GFP, Cx50-202-GFP
and Cx50-230-GFP. A total of 60 cells with each construct were used for the graph.with ERGIC-53 (Fig. S2(A) and (B)), which was only marginally bet-
ter than that seen with wild type connexin 50. Overexpression of
Cx50-FS mutant caused breakdown of the Golgi in 29% of expressing
cells while Cx50 expressing as well as non-expressing cells showed
breakdown of the Golgi in 10% of cells (Fig. 2(D) and (E)). GFP trans-
fected cells showed breakdown of the Golgi in 10% of the cells (ﬁgure
not shown). Overexpression of Cx50-FS did not affect giantin protein
levels as analysed by western blotting (Fig. 2(F)). In the cells with
intact Golgi staining, the frameshift mutant showed weak colocal-
ization with the Golgi marker (Fig. S2(C) and (D)). On staining with
TGN-38, cells overexpressing Cx50-FS mutant showed breakdown of
TGN in 55.85% of cells whereas 20.6% of cells overexpressing Cx50
showed TGN breakdown. Non-expressing cells showed breakdown
in 13–14% of the cells (Fig. 2(G) and (H)). To determine whether the
disruption of the ERGIC and Golgi by Cx50-FS mutant is a cell type
speciﬁc phenomenon, similar experiments were done in Cos-1 cell
line. Overexpression of Cx50-FS showed disruption of the ERGIC in
39.3% cells while Cx50 showed disruption in 16.75% cells (Fig. S3(A)
and (B)). Cx50-FS caused breakdown of the Golgi in 25.5% of express-
ing cells while Cx50-WT showed breakdown in 10.6% of expressing
cells (Fig. S3(C) and (D)).
Since we observed that overexpression of the frameshift mutant
caused disruption of the ERGIC and Golgi, the effect of this mutanton staining pattern of COPII and COPI vesicles was examined. COPII
coated vesicles are anterograde transport vesicles carrying protein
cargo from the ER to the ERGIC [31,32], whereas COPI vesicles are
involved in retrograde transport from the Golgi to the ERGIC or from
the ERGIC to the ER or directly from the Golgi to the ER [33]. While
we observed a disturbed pattern of Sec24C staining (COPII vesicles
and ER exit site marker) in 16% of the cells by overexpression of the
Cx50-FS mutant (Fig. S4(A) and (B)), no signiﬁcant effect was seen in
the staining pattern ofβ-COP (COPI vesiclesmarker) (Fig. S4(C)).Wild
type connexin 50 did not show any effect on the staining pattern of
either Sec24C or β-COP (Fig. S4(A)–(C)).
3.3. Aberrant sequence does not cause defective localization of mutant
Cx50
The results so far showed that the frameshift mutant is retained
in the ER and it does not move to the plasmamembrane.Whatmakes
thismutant protein to remain in the ER? Is it due to the extra 46 amino
acids that are generated by the frameshift? To test this possibility
we generated a mutant of connexin 50 lacking this extra sequence
and it consists of 1–202 amino acids of the normal Cx50 (Cx50-202).
This mutant did not show localization to the plasma membrane and
showed ER-like localization pattern like the frameshift mutant (Fig.
3(A) and (B)). Like Cx50-FS (Fig. 4(A) second row and (B)), Cx50-202
also showed good colocalization with overexpressed TC48 tyrosine
phosphatase (Fig. 4(A) third row and (B)), which localizes predomi-
nantly in the ER [25,34]. This suggested that the aberrant sequence
generated by the frameshift is not responsible for ER localization or
lack of transport of the frameshift mutant to the plasma membrane.
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Fig. 4. Colocalization of connexin 50 and its deletionmutants with GFP-TC48. (A) Hela
cells plated on coverslips were cotransfected with GFP-TC48 and Cx50-myc or the
deletion mutants. After 25 h the cells were ﬁxed, stained with anti-myc antibody and
analysed by confocal microscopy. Colocalization was seen by merging of green (GFP-
TC48) with red (connexin 50 constructs) giving yellow colour in the merged image
panel. Scale bar: 10μm(B)Bar diagramshowing correlation coefﬁcient of colocalization
between GFP-TC48 and Cx50 constructs. The graph shows mean ± SD of 40 cells with
each construct for calculation of correlation coefﬁcients. (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version of
this article.)
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Fig. 5. Effect of Cx50-202 deletion mutant on the ERGIC and Golgi. Hela cells were
transfectedwith Cx50-FS-myc and Cx50-202-myc constructs. After 25 h of transfection
the cells were double immunostainedwith anti-myc and ERGIC-53 (A) or anti-myc and
Giantin (C). The analysis was done by confocal microscopy. Scale bar: 10 μm. (B) Bar
diagram showing percentage of cells with ERGIC disruption in cells expressing (exp) or
not expressing (non-exp) connexin 50 constructs. **p < 0.01. (D) Bar diagram showing
percentage of cells with Golgi breakdown. The graphs (B, D) show mean ± SD of six
experiments and a total of 900 cells were scored. **p < 0.01.We next analysed the role of aberrant sequence of the frameshift
utant in causing the breakdown of ERGIC and Golgi. For this pur-
ose we examined the effect of overexpression of deletion construct
1–202) of connexin 50 on the ERGIC and Golgi. As compared to
he frameshift mutant the deletion mutant caused signiﬁcantly less
reakdown of the ERGIC and Golgi (Fig. 5(A)–(D)). These results sug-
est that the aberrant sequence present in the frameshift mutant
ontributes to the breakdown of ERGIC and Golgi.
.4. Identiﬁcation of domains required for localization of connexin 50
o the plasma membrane
The frameshift mutant lacks the 4th transmembrane domain and
he C-terminal cytoplasmic domain. Since aberrant sequence does
ot seem to cause mislocalization of the frameshift mutant we hy-
othesized that the loss of 4th transmembrane domain or the loss
f cytoplasmic domain may be responsible for altered localization of
he frameshift mutant. A deletion construct of connexin 50, which
as all four transmembrane domains (M1–M4) (1–230 amino acids)
Cx50-230-myc) wasmade. This construct showed localization to the
lasmamembrane in only about 3% of the cells (Fig. 3(A)–(C)) and the
taining in the plasma membrane was not as prominent as seen with
he wild type protein. The remaining cells showed intracellular stain-
ng predominantly in the ER, as shown by colocalization with TC48
Fig. 4(A) fourth row and (B)). On the other hand the Cx50-230-GFP
onstruct showed plasma membrane localization in about 30% of the
ells (Fig. 3(B) and (D)). The staining pattern in the remaining cells
as similar to that of Cx50-FS mutant protein but contained large in-
racellular foci observed in the case of Cx50. These results suggest thatthe fourth transmembrane domain is essential for localization of Cx50
to the plasmamembrane or retention in the plasmamembrane. How-
ever, it appears that the C-terminal cytoplasmic domain contributes
to efﬁcient localization of connexin 50 to the plasma membrane.
A deletion mutant of mouse connexin 50 consisting of 1–290
amino acid (corresponding to 1–294 amino acids of human connexin
50) has been shown to localize to the plasma membrane, like the
wild type protein [35]. This truncation occurs naturally in the cells
by calpain [36]. This indicated that the entire C-terminal cytoplasmic
domain may not be necessary for localization of Cx50 to the plasma
membrane. Therefore, we made a deletion construct encompassing
1–294 amino acids of human connexin 50 (Cx50-294). This construct
showed efﬁcient localization to the plasmamembrane in 50–60% cells
(Fig. 3(A)–(C)) and did not show colocalization with overexpressed
TC48 (Fig. 4(A) ﬁfth row and (B)) similar to Cx50 (Fig. 4(A) ﬁrst row
and (B)). These results suggest that membrane proximal cytoplasmic
domain (amino acids 230–294) is essential for efﬁcient localization of
Cx50 to the plasma membrane.
3.5. Effect of deletion mutants on transport and localization of
connexin 50 to the plasma membrane
Our deletion analysis showed that the construct Cx50-202 does
not localize to the plasma membrane and it remains predominantly
in the ER. This defective localizationmaybedue to adefect in its trans-
port from the ER or anchoring in the plasma membrane. A transport
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Fig. 6. Effect of deletion constructs on plasma membrane localization of full length
Cx50. (A) Hela cells were cotransfected with 1:2.5 ratio of plasmids expressing Cx50-
GFP and Cx50-myc or Cx50-FS-myc or Cx50-202-myc or Cx50-230-myc or Cx50-294-
myc and ﬁxed after 25 h of transfection. Cells were immunostained with anti-myc
antibody and analysed by confocal microscopy to check the effect of overexpression
of the deletion mutants on plasma membrane localization of Cx50. (B) Bar diagram
showing the percentage of cells with plasma membrane localization of Cx50 in the
presence of various mutants of Cx50. The values in the bar diagram are mean ±
SD of four experiments. A total of 300 cells were used with each construct. ***p <
0.001. (C) Bar diagram showing the correlation coefﬁcient of colocalization of Cx50-
GFP (intracellular) with indicated mutants of Cx50. The graph shows mean ± SD of 40
cells with each construct. (D) Bar diagram showing the percentage of cells with plasma
membrane localization of Cx50 in the presence of Cx50-FS at a ratio of 1:1. *p < 0.05.
The graphs show mean ± SD of four experiments. A total of 300 cells were counted.
Fig. 7. The frameshift mutant as well as Cx50-202 construct interact with the wild
type connexin 50. Hela cells were cotransfected with Cx50-GFP and Cx50-FS-myc (A)
or Cx50-GFP and Cx50-202-myc (B) in the ratio of 1:2.5. After 30 h of overexpression,
cell lysates were prepared and immunoprecipitation was carried out using anti-mycdefective deletionmutantmay inhibit the transport of full length con-
nexin 50. We examined this possibility by coexpressing myc-tagged
deletion constructs with GFP tagged full length connexin 50 in the
ratio of 2.5:1. Coexpression of deletion mutant, Cx50-202, resulted in
inhibition of plasmamembrane localization of full length connexin 50
(Fig. 6(A) third row and (B)). Quantitative analysis showed that in 80%
of the cells coexpressing deletionmutant, the Cx50-GFP did not show
any staining in the plasma membrane and accumulated inside the
cell. The intracellular Cx50-GFP showed strong colocalizationwith the
deletionmutant 1–202, possibly in the ER (Fig. 6(A) third rowand (C)).
The other deletion construct Cx50-230 that encompasses transmem-
brane domains M1–M4 also inhibited the localization of connexin 50
to the plasma membrane (Fig. 6(A) fourth row and (B)). However,
the deletion construct Cx50-294 that shows good membrane local-
ization, did not inhibit localization of full length connexin 50 to the
plasma membrane (Fig. 6(A) last row and (B)). These results suggest
that the deletion constructs of connexin 50 that are defective in local-
ization to the plasma membrane also cause inhibition of transport of
Cx50 to the plasma membrane; therefore, these mutants (Cx50-202
and Cx50-230) are likely to be defective in their transport from the
ER to the plasma membrane. The plasma membrane localization of
Cx50-294was examined by costaining the Cx50-294 transfected cells
with β-catenin. While Cx50-294 showed good colocalization with β-
catenin at the junctionalmembranes, Cx50-202 and Cx50-230 did not
show any colocalization with β-catenin at the plasmamembrane and
showed intracellular localization (Fig. S5).
Since the frameshift mutant of connexin 50 is localized in the
ER, we examined the affect of coexpressing the frameshift mutant
on the localization of Cx50. Coexpression of the frameshift mutant
resulted in inhibition of localization of Cx50 to the plasmamembrane
in most of the cells (Fig. 6(A) second row and (B)). However when the
frameshift mutant and Cx50 were coexpressed in 1:1 ratio, there was
only amarginal effect in localization of Cx50 to the plasmamembrane
(Fig. 6(D)).
Connexin polypeptides interact with each other to form homo or
hetero-oligomers in the ER before their transport to the plasmamem-
brane. The ability of the frameshift mutant to interact with wild type
Cx50 was examined by coimmunoprecipitation. The frameshift mu-
tant was able to coimmunoprecipitate wild type connexin 50 (Fig.
7(A)). The deletion mutant Cx50-202 was also able to coimmuno-
precipitate wild type Cx50 (Fig. 7(B)). These results show that even
though the Cx50-FS and Cx50-202 form a complex with Cx50, these
proteins do not get co-transported to the plasma membrane along
with Cx50. Instead, these mutants inhibit the transport of Cx50 to the
plasma membrane.
4. Discussion
Most of the mutants of connexin 50 that cause cataract are dom-
inant and recessive mutants are rare [6,18]. The frameshift mutant
of Cx50 studied here is a recessive mutant that causes congenital
cataract [20]. The results presented here suggest that this mutant is a
loss of functionmutation because it does not reach plasmamembrane
wherewild type connexin50performs its functionasgap junctionand
hemichannel. This mutant has 46 aberrant amino acids after codon
202 that are generated due to frameshift. However, the aberrant se-
quence generatedby frameshift doesnot seemtobe responsible for its
improper localization because deletion of aberrant sequence resulted
in a protein that, like the frameshift mutant, did not reach plasma
membrane and localized predominantly in the ER. The frameshift
mutant, when co-expressed with Cx50, was not able to reach the
plasma membrane even though it forms a complex with the wild
type connexin 50. The inability to localize at the plasma membrane
may be due to its defective transport or due to defective retention in
the plasma membrane. However, complete absence of the frameshift
mutant from the plasma membrane, and inhibition of anterograde
antibody or control IgG antibody. The samples were later subjected to western blotting
with the indicated antibodies. Input is 5% lysate.
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mransport of wild type connexin 50, suggest that this mutant is likely
o be defective in transport to the plasma membrane.
While examining the colocalization of the frameshift mutant with
arkers of ERGIC and Golgi, we observed that this mutant caused
reakdown of the ERGIC and Golgi in some of the cells. Earlier stud-
es have already shown that transfection per se causes disruption of
he ERGIC and Golgi [37,38], but the breakdown observed with the
rameshift mutant is highly signiﬁcant compared to that observed
ith wild type or control transfections. The aberrant sequence seems
o play some role in breakdown of the Golgi and ERGIC because dele-
ion of aberrant sequence resulted in less breakdown of these or-
anelles. The breakdown of Golgi may be due to inhibition of antero-
rade transport because thismutant inhibits transport of Cx50-WT to
ome extent. One possible explanation for transport inhibition is that
x50-FS may be interacting, directly or indirectly, with a component
f transport machinery, thereby affecting its function. This hypothe-
is is supported by our observation that Cx50-FS expression disrupts
ec24c staining in 16% cells. Sec24c is present in the ER exit site and
lso in the COPII vesicles. Sec23/24 heterodimer is a structural com-
artment of COPII and is also involved in the recruitment of cargo (by
irect interaction).
It is somewhat surprising that in spite of causing breakdown of
he ERGIC and Golgi, and inhibiting the localization of normal con-
exin 50 to the plasma membrane, the frameshift mutant causes re-
essive cataract. Since at lower level of expression, the frameshift
utant showed only a marginal effect on localization of Cx50-WT to
he plasmamembrane, the effectmay not be enough to cause cataract
n heterozygous condition. Another possible explanation for recessive
henotype of this frameshiftmutant is that its effect on the ERGIC and
olgi are not severe enough to cause cell death or cataract. However,
he available data do not rule out the possibility that this mutant in
eterozygous condition contributes to some extent to cataract devel-
pment in the adults.
Connexins have been studied extensively with respect to their
tructure, oligomerization and function as gap junctions or hemichan-
els in the plasma membrane. Transport of connexins to the plasma
embrane occurs through the ER-Golgi mediated secretory pathway
9,10]. Deletion analysis has shown that connexin 32 polypeptide ex-
ending fromN-terminus past M3 is required for oligomerization and
ssembly with full length connexin 32, and M4 and C-terminal cy-
oplasmic domain are not required for this process [10,39]. The role
f carboxy terminal region of connexins have been analysed in gap
unction function and plaque formation [39–42]. Cx50 interacts with
O-1 and contains a PDZ domain-binding motif at the extreme C-
erminus [40,43]. The interaction of this motif with ZO-1 are required
or targeting of Cx50 to the gap junction plaques and formation of ac-
ive channels [40]. However, with respect to localization of a deletion
onstruct (1–290 amino acids) to the plasma membrane, the results
f Chai et al. [40] are apparently contradictory to the observation of
eRosa et al. who showed that a deletion mutant of mouse connexin
0 (1–290 amino acids), corresponding to 1–294 amino acid of human
x50, localizes to the plasma membrane [35]. Our results show that
ourth transmembrane domain and a portion of cytoplasmic domain
xtending up to amino acid 294 are required for localization of human
onnexin 50 to the plasma membrane. Those deletion constructs of
x50 that are defective in localization to plasma membrane are re-
ained in the ER and also inhibit localization of full length Cx50 to
lasma membrane, suggesting therefore, that these are defective in
ransport.
What is the role of M4 in localization or transport? One possibility
s that it is required for proper assembly of Cx50 into transport com-
etent complex. Alternatively, the M4may be involved in interaction
ith a transport protein. These two possibilities are not mutually ex-
lusive. The C-terminal cytoplasmic domain extending up to amino
cid 294 may be involved in retention of connexin 50 in the plasma
embrane, or like M4, it may be involved in facilitating transportfrom the ER to the plasma membrane.
In conclusion, our results show that a cataract-causing frameshift
mutant of connexin 50 is defective in its localization to the plasma
membrane and shows ER localization possibly due to defective trans-
port from the ER. This is likely to result in loss of function of connexin
50 leading to recessive phenotype of congenital cataract associated
with this frameshift mutant. We have identiﬁed a role for the fourth
transmembrane domain and a sequence in the adjacent cytoplasmic
domain in localization of connexin 50 to the plasma membrane. The
M4 is likely to be involved in facilitating the transport of Cx50 from
the ER, whereas the adjacent cytoplasmic region may be facilitating
the transport or anchoring of the protein in the plasma membrane.
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